Home › Large Granular Lymphocytic Leukemia › New York › New York City
Large Granular Lymphocytic Leukemia clinical trials in New York City, NY
4 studies for Large Granular Lymphocytic Leukemia are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
RecruitingPhase 1/2
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Weill Cornell Medical Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Large Granular Lymphocytic Leukemia trials in other cities
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.